WENDY NIX: Open Payments
NPI 1760710677 · CLINTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,346 in 86 payments from 18 companies in 2025. Trend: 2023 $1,935 · 2024 $1,578 · 2025 $1,346
Food & beverage: $1,346
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $245 |
| Novo Nordisk Inc | 17 | $211 |
| AstraZeneca Pharmaceuticals LP | 8 | $187 |
| PFIZER INC. | 13 | $141 |
| Lilly USA, LLC | 9 | $125 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Phathom Pharmaceuticals, Inc. | 4 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $39 |
Products named: UBRELVY, NURTEC ODT, Wegovy, REXULTI, MOUNJARO, BREZTRI, Ozempic, FARXIGA.
Industry payments across SC — which companies pay providers there.
